Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth

We recently compiled a list of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Prenetics Global Limited (NASDAQ:PRE) is one of the most promising stocks on our list TheFly reported on June 16 that Benchmark initiated coverage of PRE with a Bu

We recently compiled a list of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds.

Prenetics Global Limited (NASDAQ:PRE) is one of the most promising stocks on our list

TheFly reported on June 16 that Benchmark initiated coverage of PRE with a Buy rating and a $30 price target. The firm highlighted the company’s IM8 health and wellness brand, which targets the expanding nutritional supplements market. Benchmark noted that PRE is positioned for long-term growth through broader product offerings, expansion into related categories, diversification of marketing channels, and increasing international market penetration.

On June 10, Prenetics Global Limited (NASDAQ:PRE) reported its first quarter 2026 financial results, highlighted by strong growth from its IM8 health and longevity brand. Total revenue reached $36.0 million, including $33.8 million generated by IM8, representing substantial year-over-year and sequential growth. Encouraged by the brand’s performance, the company increased its full-year 2026 IM8 revenue outlook to between $190 million and $210 million and projected continued momentum for the second quarter.

Leave a Reply

Your email address will not be published. Required fields are marked *